Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project

Keyphrases

• Alzheimer's Disease 100%
• Precision Medicine 100%
• Mild Cognitive Impairment 66%
• Cognitive Decline 66%
• Montreal Cognitive Assessment (MoCA) 66%
• Potential Contributor 66%
• Assessment Score 66%
• Insulin Resistance 33%
• Clinical Trials 33%
• Dysregulation 33%
• Change Score 33%
• Randomized Controlled Trial 33%
• Chronic Infection 33%
• Personalized Medicine 33%
• Therapeutic Approaches 33%
• Vascular Disease 33%
• Serious Adverse Events 33%
• Effective Strategies 33%
• Patients with Dementia 33%
• Biochemical Parameters 33%
• Treatment Modalities 33%
• Inflammation Markers 33%
• Brain Magnetic Resonance Imaging 33%
• Proof of Concept Study 33%
• Nocturnal Hypoxemia 33%
• Randomized Controlled Clinical Trial 33%
• Drug Candidates 33%
• Protein Glycation 33%
• Single Treatment 33%
• Alzheimer 33%
• Toxin Exposure 33%
• Therapeutic Method 33%
• Dysbiosis 33%
• Neurocognitive 33%
• Neurodegenerative Processes 33%
• Set Size 33%
• Cognitive Improvement 33%
• MRI Volumetry 33%
• Nutrient Deficiency 33%
• Toxicant Exposure 33%
• Drug Therapeutics 33%
• CNS Vital Signs 33%
• Resistance Protein 33%

Medicine and Dentistry

• Alzheimer's Disease 100%
• Personalized Medicine 100%
• Magnetic Resonance Imaging 50%
• Mild Cognitive Impairment 50%
• Montreal Cognitive Assessment 50%
• Infection 25%
• Clinical Trial 25%
• Adverse Event 25%
• Randomized Controlled Trial 25%
• Insulin Resistance 25%
• Vascular Disease 25%
• Hypoxemia 25%
• Controlled Clinical Trial 25%
• Vital Sign 25%
• Nutritional Deficiency 25%
• Dysbiosis 25%
• Protein Glycosylation 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 100%
• Mild Cognitive Impairment 66%
• Infection 33%
• Insulin Resistance 33%
• Clinical Trial 33%
• Adverse Event 33%
• Inflammation 33%
• Randomized Controlled Trial 33%
• Vascular Disease 33%
• Hypoxemia 33%
• Controlled Clinical Trial 33%
• Dysbiosis 33%
• Nutritional Deficiency 33%